Pfizer acquires Seagen for cancer treatment development

March 14, 2023
Current context: Pfizer will spend 43 billion dollar to buy Seagen for cancer research development. Pfizer will pay 229 dollar per share to Seagen.
Pfizer acquires Seagen for cancer treatment development
  • Both the companies will collaborate to provide Seagen’s antibody drug conjugate (ADC) with the help of Pfizer’s expertise in the field.
  • Seagen is a Washington based company which is a biotech drug developer. It mainly specializes in cancer treatment.
  • Seagen’s top seller, Adcertis, also made a deal with Pfizer’s Array BioPharma to treat breast cancer.
  • Pfizer is a New York based company, has also contributed 11.6 billion dollars to migraine treatment developer Biohaven Pharmaceuticals.
  • Pfizer concludes that Seagen can provide more than 10 billion dollars revenue until 2030 in the field of cancer treatment.

Question:

Q.1 Pfizer has collaborated with_______ for cancer treatment development.
a. ICICI
b. AIIMS
c. Seagen
d. IIT Kanpur

Continue on BankExamsToday

Revise notes, practice questions and resume anytime.

About Me

Ramandeep Singh

Ramandeep Singh

Educator & Banking Expert

I'm Ramandeep Singh, your guide to banking and insurance exams. With 14 years of experience and over 5000 successful selections, I understand the path to success firsthand, having transitioned from Dena Bank and SBI. I'm passionate about helping you achieve your banking and insurance dreams.

14+
Years Experience
5000+
Selections
Ex-BoB
Banker